WeVote
Log In

Bill

Bill

S 5267

A bill to amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using Accountable Produce is Medicine.

119th Congress Introduced by Jim Banks and 3 co-sponsors

Mandate CMMI to test a produce-based model in Medicare/Medicaid to treat produce as medicine, evaluate health outcomes, and potential cost savings.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 5267

Bill Overview

  • Official Title: A bill to amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using “Accountable Produce is Medicine.”
  • Session & Jurisdiction: United States Senate, 119th Congress.
  • Introduced: August 5, 2026; Read twice and referred to the Committee on Finance.
  • Sponsors:
    • Co-sponsors: Alex Padilla, Roger Marshall, Jim Banks

Primary Purpose and Intent

  • The bill aims to amend existing law (title XI of the Social Security Act) to mandate the Center for Medicare and Medicaid Innovation (CMMI) to test a new model that leverages farm-to-clinic or produce-based interventions to reduce chronic diseases.
  • The core concept is framed around treating produce (fruits and vegetables) as a therapeutic or preventive “medicine” component within Medicare/Medicaid programs, with the goal of improving health outcomes and potentially lowering disease burden related to chronic conditions.

Key Provisions and Changes

  • Mandatory Testing Model: Requires CMMI to design, test, and evaluate a model that uses produce-based interventions as a means to reduce chronic disease prevalence or progression among beneficiaries.
  • Framework for Intervention: The model would likely involve arrangements where access to produce, nutrition education, or incentives to consume produce are integrated into covered services or care pathways for beneficiaries with chronic conditions.
  • Evaluation and Metrics: The bill would necessitate a formal evaluation plan to assess health outcomes, cost implications, and potential reductions in chronic disease incidence or complication rates.
  • Payment and Implementation: May establish funding streams, payment methodologies, or demonstration parameters to support pilot testing, scale considerations, and interagency coordination.
  • Regulatory Alignment: Amendments to title XI to authorize the testing mechanism and to ensure compatibility with existing Medicare and Medicaid policy structures.

Note: The bill’s summary emphasizes a novel “Accountable Produce is Medicine” approach, positioning produce-based interventions as accountable health strategies within federal care programs.

Who and What Is Affected

  • Beneficiaries: Individuals enrolled in Medicare and/or Medicaid who participate in the CMMI-tested model.
  • CMMI: The agency would be directed to design, implement, and evaluate the pilot or demonstration project.
  • Healthcare Providers and Suppliers: Providers may engage in produce-based treatment or referral pathways as part of care plans.
  • Industry Stakeholders: Producers, grocers, nutrition services, and community organizations involved in delivering fresh produce or nutrition support could participate or partner in the model.
  • Payers: Federal Medicare/Medicaid programs and potentially related demonstration funds would finance the pilot and evaluation.

Procedural and Timeline Considerations

  • Enactment Path: As a Senate bill, it would need passage by both chambers (Senate and House) and presidential approval to become law.
  • Implementation Timeline: The bill requires CMMI to test a model, which implies a phased timeline starting with design and deployment of a demonstration, followed by evaluation and reporting. Specific milestones (e.g., start date, duration, interim findings) would be detailed in the enacted text or accompanying committee reports.
  • Reporting: Likely requires periodic reporting to Congress on outcomes, cost savings, and scalability of the produce-based model.

Potential Impacts and Considerations

  • Health Outcomes: If effective, could contribute to reductions in chronic disease metrics (e.g., incidence, management, hospitalization rates) through improved nutrition.
  • Cost Implications: Demonstration costs versus potential long-term savings from reduced chronic disease burden.
  • Access and Equity: Could expand access to healthy foods for underserved communities as part of care models.
  • Implementation Challenges: Operationalizing produce-based interventions within federal programs, ensuring quality, freshness, supply chain integrity, and beneficiary adherence.

This summary reflects the bill’s stated aim to institutionalize a test of “Accountable Produce is Medicine” within CMMI, emphasizing evidence-based evaluation to determine health and fiscal impacts. For detailed provisions, exact language, and formal definitions, the bill’s text and committee reports should be consulted.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.